Plenary Sessions and Speakers

Plenary Sessions and Speakers

Get a sneak peek below at the exciting keynote lectures and plenary sessions that will be part of the IPVC 2023 scientific program. Please note that all sessions are going to be LIVE. All times below are in Washington DC Local Time – EST (GMT-5).

If you want to be the first to know all IPVC 2023 updates, sign up for our newsletter here.

Tuesday,
April 18
16:00-17:30

OPENING CEREMONY AND KEYNOTE LECTURE

  • Comparing and contrasting Covid-19 control with HPV control and elimination

Barney Graham, USA

Wednesday,
April 19
11:00-12:30

PLENARY SESSION 1

  • One-dose HPV vaccination overview and a focus on the KENSHE data

Ruanne Barnabas, USA

  • New prophylactic HPV vaccines

Richard Roden, USA

  • Therapeutic vaccines in particular with clinical outcomes such as CIN 3

Mayumi Nakagawa, USA

Thursday,
April 20
8:30-10:00

PLENARY SESSION 2

  • Lessons learned from other disease control programs such as HIV

Helen Rees, South Africa

  • What can we learn from the hepatitis B model in elimination of HPV-related diseases?

 Mark Kane, USA

  • Anal cancer control approaches

Joel Palefsky, USA

 

16:40-18:10

PLENARY SESSION 3

  • Mastomys Coucha: a unique animal model for papillomavirus-induced skin carcinogenesis

Frank Rosl, Germany

  • Pros and cons of Beta HPVs as causative agents in skin cancer

Denise Galloway, USA

  • Epidemiology and biology of Beta human papillomavirus types

TBD

Friday,
April 21
11:00-12:30

PLENARY SESSION 4

  • Covid-19 effect on cervical screening

Mona Saraiya, USA

  • Re-invigorating efforts towards cervical cancer elimination: mitigating the impact of Covid-19

Karen Canfell, Australia

  • What will it take (and how to) achieve cervical cancer elimination goal by 2030 with a perspective for low and middle income countries?

Yin Ling Woo, Malaysia

 

16:30-18:00

CLOSING CEREMONY AND KEYNOTE LECTURE

  • The future is now

 Douglas Lowy, USA

Visit 2021 website Membership